Patients with cholangiocarcinoma have a low life expectancy, with a typical 5-year survival rate of less than 5%. Due to the variability of individuals, it is not possible to make a generalization.
Cholangiocarcinoma is a malignant tumor of liver and biliary system originated from epithelial cells of bile ducts. Its etiology has not been clarified, and it may be caused by choledochal cysts, hepatic and bile duct stones, viral hepatitis, viral infections and other factors. Patients may suffer from abdominal discomfort, jaundice, abdominal pain, fatigue, nausea and other symptoms.
The outcome of patients with cholangiocarcinoma is poor, and the 5-year survival rate is less than 5%. As most cholangiocarcinoma patients with clinical symptoms are already in the stage of tumor progression, their radical resection rate is low, and the chances of postoperative recurrence are high, in general, the recurrence rate is more than 60% in 5 years after operation, and a few patients die within 1 year after clearing cholangiocarcinoma.
Due to the different personal conditions of patients and the severity of the disease, it is impossible to generalize what the exact life expectancy is.
Once patients are diagnosed with cholangiocarcinoma, they should actively cooperate with doctors to take relevant treatment measures, so as to avoid delaying the condition.